Effectiveness of Standard Treatment for Foot Ulcer of Diabetic Patients

Document Type : مقاله کوتاه

Authors

1 Associate Professor, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan AND Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Associate Professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 General Practitioner, Researcher, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

5 MSc Student, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Diabetes mellitus is a common chronic disease and an important leading cause of death in the world. It is associated with potentially serious complications. Diabetic foot ulcer is a major debilitating complication of diabetes and in severe cases result in lower extremity amputation. Several multidisciplinary approaches are used for the treatment of diabetic foot ulcer. The main objective of this study was evaluating the effectiveness of standard treatment in patients with diabetic foot ulcer.Methods: Patients with diabetic foot ulcer entered this study. Detailed medical history was recorded for the patients and each participant signed the informed consent. Standard treatment approach including patient education, diabetes control, infection treatment, offloading and weekly debridement was started by our therapeutic team.Findings: 56 patients with diabetic foot ulcer were evaluated in this study. The mean age of the patients was 59.46±12.66 years. 62 percent of the patients achieved significant wound improvement (decreased wound area and control of infection) with the mean of 4.73 weeks of treatment (P < 0.05).Conclusion: The results of this study present a further documentation of the effectiveness of standard treatment care for diabetic foot ulcer. This multidisciplinary approach aiming the major pathophysiologic components of the disease can lead to significant improvement with few side effects. 

Keywords


  1. Kahn R. Diabetes technology--now and in the future. Lancet 2009; 373(9677): 1741-3.
  2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366(9498): 1736-43.
  3. Lee KM, Kim WH, Lee JH, Choi MS. Risk factors of treatment failure in diabetic foot ulcer patients. Arch Plast Surg 2013; 40(2): 123-8.
  4. Margolis DJ, Malay DS, Hoffstad OJ, Leonard CE, MaCurdy T, de Nava KL, et al. Incidence of Diabetic Foot Ulcer and Lower Extremity Amputation Among Medicare Beneficiaries, 2006 to 2008: Data Points #2. 2011.
  5. Kalish J, Hamdan A. Management of diabetic foot problems. J Vasc Surg 2010; 51(2): 476-86.
  6. Armstrong D, Dos RE, Andersen C, Koller A, Roukis TS. Wound care and diabetic foot. Foot Ankle Spec 2009; 2(3): 146-50.
  7. Hinchliffe RJ, Valk GD, Apelqvist J, Armstrong DG, Bakker K, Game FL, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S119-S144.
  8. Frykberg RG. Diabetic foot ulcers: pathogenesis and management. Am Fam Physician 2002; 66(9): 1655-62.
  9. Bahrami A, Aliasgarzadeh A, Sarabchian M, Mobasseri MM, Heshmat R, Gojazadeh M. Efficacy of oral angipars in Chronic diabetes foot ulcer: a double blind placebo controlled study. Iran J Endocrinol Metab 2009; 11(6): 647-55. [In Persian].
  10. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35(6): 528-31.
  11. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986; 204(3): 322-30.
  12. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13(5): 513-21.
  13. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003; 90(2): 133-46.
  14. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293(2): 217-28.
  15. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ. Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care 2005; 28(8): 1869-75.
  16. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003; 196(2): 245-50.
  17. Venturi ML, Attinger CE, Mesbahi AN, Hess CL, Graw KS. Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review. Am J Clin Dermatol 2005; 6(3): 185-94.
  18. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366(9498): 1704-10.
  19. Saap LJ, Donohue K, Falanga V. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol Surg 2004; 30(8): 1095-100.
  20. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999; 7(5): 335-46.
  21. Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005; 92(1): 24-32.
  22. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; (1): CD003556.
  23. Lipsky BA, Berendt AR. Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype? Diabetes Care 2010; 33(5): 1143-5.
  24. Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther 2012; 3(1): 4.